Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2014) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy

(2014) Ching-Lan Lu et al.   VACCINE

Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147)

(2013) K L Bsc Slayter et al.   INTERNATIONAL JOURNAL OF STD & AIDS

HIV and Influenza Virus Infections Are Associated With Increased Blood Pneumococcal Load: A Prospective, Hospital-Based Observational Study in South Africa, 2009-2011

(2013) N. Wolter et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil

(2013) Yeh-Li Ho et al.   VACCINE

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

(2013) Lisa A. Jackson et al.   VACCINE

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

(2013) Lisa A. Jackson et al.   VACCINE

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

(2013) Lisa A. Jackson et al.   VACCINE

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy

(2013) Ching-Lan Lu et al.   Human Vaccines & Immunotherapeutics

Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine

(2012) William C. Gruber et al.   Annals of the New York Academy of Sciences

Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients

(2012) Ching-Lan Lu et al.   VACCINE

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals

(2012) Marta C. Nunes et al.   Human Vaccines & Immunotherapeutics

Invasive pneumococcal disease among HIV-positive individuals, 2000–2009

(2011) Zheng Yin et al.   AIDS

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

(2011) David Cooper et al.   VACCINE

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization

(2010) Adam L Cohen et al.   AIDS

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults

(2010) Maria Peñaranda et al.   AIDS

Cellular CD4 T Cell Responses to the Diphtheria‐Derived Carrier Protein of Conjugated Pneumococcal Vaccine and Antibody Response to Pneumococcal Vaccination in HIV‐Infected Adults

(2010) Claire Rabian et al.   CLINICAL INFECTIOUS DISEASES

Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV‐Infected Adults with a Toll‐Like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial

(2010) Ole S. Søgaard et al.   CLINICAL INFECTIOUS DISEASES

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review

(2010) RH Pedersen et al.   HIV MEDICINE

A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV‐Infected Adults

(2010) Nancy F. Crum‐Cianflone et al.   JOURNAL OF INFECTIOUS DISEASES

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults

(2010) Neil French et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults

(2008) Meng Chen et al.   VACCINE

The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease

(2007) Sandra J Bliss et al.   LANCET INFECTIOUS DISEASES